Published in Proc Natl Acad Sci U S A on March 23, 2010
Systems metabolic engineering of microorganisms for natural and non-natural chemicals. Nat Chem Biol (2012) 2.17
Regulation of transcription by unnatural amino acids. Nat Biotechnol (2011) 1.64
An integrated open framework for thermodynamics of reactions that combines accuracy and coverage. Bioinformatics (2012) 1.16
L-malate production by metabolically engineered Escherichia coli. Appl Environ Microbiol (2010) 1.04
An economical method for production of (2)H, (13)CH3-threonine for solution NMR studies of large protein complexes: application to the 670 kDa proteasome. PLoS One (2012) 0.97
A synthetic recursive "+1" pathway for carbon chain elongation. ACS Chem Biol (2012) 0.95
A novel muconic acid biosynthesis approach by shunting tryptophan biosynthesis via anthranilate. Appl Environ Microbiol (2013) 0.94
Directed evolution as a powerful synthetic biology tool. Methods (2012) 0.91
Engineering a cyanobacterium as the catalyst for the photosynthetic conversion of CO2 to 1,2-propanediol. Microb Cell Fact (2013) 0.91
Assessing directed evolution methods for the generation of biosynthetic enzymes with potential in drug biosynthesis. Future Med Chem (2011) 0.90
Production in Escherichia coli of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) with differing monomer compositions from unrelated carbon sources. Appl Environ Microbiol (2011) 0.83
A highly selective biosynthetic pathway to non-natural C50 carotenoids assembled from moderately selective enzymes. Nat Commun (2015) 0.82
Novel hydrated graphene ribbon unexpectedly promotes aged seed germination and root differentiation. Sci Rep (2014) 0.79
Protein engineering for metabolic engineering: current and next-generation tools. Biotechnol J (2013) 0.78
A novel biocatalyst for efficient production of 2-oxo-carboxylates using glycerol as the cost-effective carbon source. Biotechnol Biofuels (2015) 0.76
Family-wide structural characterization and genomic comparisons decode diversity-oriented biosynthesis of thalassospiramides by marine proteobacteria. J Biol Chem (2016) 0.75
Production of (S)-2-aminobutyric acid and (S)-2-aminobutanol in Saccharomyces cerevisiae. Microb Cell Fact (2017) 0.75
Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate L-pipecolic acid in Escherichia coli. Microb Cell Fact (2017) 0.75
Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol (2006) 40.15
Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. Nucleic Acids Res (1997) 13.15
Biotechnological production of amino acids and derivatives: current status and prospects. Appl Microbiol Biotechnol (2005) 2.30
Industrial methods for the production of optically active intermediates. Angew Chem Int Ed Engl (2004) 2.19
Combinatorial and computational challenges for biocatalyst design. Nature (2001) 2.11
The treatment of epilepsy in developing countries: where do we go from here? Bull World Health Organ (2003) 2.00
Expanding metabolism for biosynthesis of nonnatural alcohols. Proc Natl Acad Sci U S A (2008) 1.86
Conformational flexibility in glutamate dehydrogenase. Role of water in substrate recognition and catalysis. J Mol Biol (1993) 1.67
Amino acid biosynthesis in the spirochete Leptospira: evidence for a novel pathway of isoleucine biosynthesis. J Bacteriol (1974) 1.60
Engineering the metabolism of Escherichia coli W3110 for the conversion of sugar to redox-neutral and oxidized products: homoacetate production. Proc Natl Acad Sci U S A (2003) 1.57
Amino acid production processes. Adv Biochem Eng Biotechnol (2003) 1.54
Novel biosynthetic approaches to the production of unnatural amino acids using transaminases. Trends Biotechnol (1998) 1.38
Production of L -alanine by metabolically engineered Escherichia coli. Appl Microbiol Biotechnol (2007) 1.30
Cloning and characterization of the Escherichia coli K-12 alanine-valine transaminase (avtA) gene. J Bacteriol (1987) 1.28
Improving NADPH availability for natural product biosynthesis in Escherichia coli by metabolic engineering. Metab Eng (2009) 1.27
2-Ketobutyrate: a putative alarmone of Escherichia coli. Mol Gen Genet (1983) 1.22
Alternate pathway for isoleucine biosynthesis in Escherichia coli. J Bacteriol (1972) 1.03
Branched-chain amino acid biosynthesis in Salmonella typhimurium: a quantitative analysis. J Bacteriol (1998) 0.98
A new antiepileptic drug. J Neurol Neurosurg Psychiatry (2002) 0.96
Branched-chain amino acid aminotransferase of Escherichia coli: overproduction and properties. J Biochem (1988) 0.94
The threonine story. Adv Biochem Eng Biotechnol (2003) 0.91
A threonine synthase homolog from a mammalian genome. Biochem Biophys Res Commun (2006) 0.89
Allosteric regulation of Bacillus subtilis threonine deaminase, a biosynthetic threonine deaminase with a single regulatory domain. Biochemistry (2008) 0.89
Purification and catalytic properties of L-valine dehydrogenase from Streptomyces cinnamonensis. Biochem J (1989) 0.88
Multidrug-resistant tuberculosis: this is the cost. Ann N Y Acad Sci (2001) 0.86
Modular coenzyme specificity: a domain-swopped chimera of glutamate dehydrogenase. Proteins (2009) 0.81
Analysis of the quaternary structure, substrate specificity, and catalytic mechanism of valine dehydrogenase. J Biol Chem (1997) 0.80
IRE1 signaling affects cell fate during the unfolded protein response. Science (2007) 9.01
A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature (2009) 7.96
Non-fermentative pathways for synthesis of branched-chain higher alcohols as biofuels. Nature (2008) 6.68
Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell (2009) 4.59
Regulated Ire1-dependent decay of messenger RNAs in mammalian cells. J Cell Biol (2009) 4.51
Direct photosynthetic recycling of carbon dioxide to isobutyraldehyde. Nat Biotechnol (2009) 3.63
A synthetic gene-metabolic oscillator. Nature (2005) 3.26
Metabolic engineering of Escherichia coli for 1-butanol production. Metab Eng (2007) 3.17
Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis (2002) 2.76
Global expression profiling of acetate-grown Escherichia coli. J Biol Chem (2002) 2.61
Co-expression pattern from DNA microarray experiments as a tool for operon prediction. Nucleic Acids Res (2002) 2.50
Epigenetic regulation of Nanog expression by Ezh2 in pluripotent stem cells. Cell Cycle (2011) 2.45
Divergent effects of PERK and IRE1 signaling on cell viability. PLoS One (2009) 2.30
Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax. J Infect Dis (2004) 2.29
Driving forces enable high-titer anaerobic 1-butanol synthesis in Escherichia coli. Appl Environ Microbiol (2011) 2.19
Transcriptome-based determination of multiple transcription regulator activities in Escherichia coli by using network component analysis. Proc Natl Acad Sci U S A (2003) 2.03
Engineering the isobutanol biosynthetic pathway in Escherichia coli by comparison of three aldehyde reductase/alcohol dehydrogenase genes. Appl Microbiol Biotechnol (2009) 1.94
Conversion of proteins into biofuels by engineering nitrogen flux. Nat Biotechnol (2011) 1.91
Expanding metabolism for biosynthesis of nonnatural alcohols. Proc Natl Acad Sci U S A (2008) 1.86
Pharmacological brake-release of mRNA translation enhances cognitive memory. Elife (2013) 1.85
Evolution, genomic analysis, and reconstruction of isobutanol tolerance in Escherichia coli. Mol Syst Biol (2010) 1.75
Metabolic engineering for advanced biofuels production from Escherichia coli. Curr Opin Biotechnol (2008) 1.69
ATP drives direct photosynthetic production of 1-butanol in cyanobacteria. Proc Natl Acad Sci U S A (2012) 1.68
An integrated network approach identifies the isobutanol response network of Escherichia coli. Mol Syst Biol (2009) 1.66
Engineering Corynebacterium glutamicum for isobutanol production. Appl Microbiol Biotechnol (2010) 1.65
Metabolic engineering of cyanobacteria for 1-butanol production from carbon dioxide. Metab Eng (2011) 1.62
gNCA: a framework for determining transcription factor activity based on transcriptome: identifiability and numerical implementation. Metab Eng (2005) 1.60
Resistance to diet-induced obesity in mice with synthetic glyoxylate shunt. Cell Metab (2009) 1.56
Antibody-mediated rejection despite inhibition of terminal complement. Transpl Int (2014) 1.52
Single-gene disorders: what role could moonlighting enzymes play? Am J Hum Genet (2005) 1.52
Time course of changes in collateral blood flow and isolated vessel size and gene expression after femoral artery occlusion in rats. Am J Physiol Heart Circ Physiol (2004) 1.50
Integrated network analysis identifies nitric oxide response networks and dihydroxyacid dehydratase as a crucial target in Escherichia coli. Proc Natl Acad Sci U S A (2007) 1.49
Directed evolution of Methanococcus jannaschii citramalate synthase for biosynthesis of 1-propanol and 1-butanol by Escherichia coli. Appl Environ Microbiol (2008) 1.45
Ensemble modeling of metabolic networks. Biophys J (2008) 1.44
Integrated electromicrobial conversion of CO2 to higher alcohols. Science (2012) 1.42
Microbial production of advanced transportation fuels in non-natural hosts. Curr Opin Biotechnol (2009) 1.41
Design of artificial cell-cell communication using gene and metabolic networks. Proc Natl Acad Sci U S A (2004) 1.40
Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax. Infect Immun (2007) 1.40
Re: Tibial Stress Fracture Secondary to Half-pins in Circular Ring External Fixation for Charcot Foot. Foot Ankle Int (2014) 1.38
Critique of hyperglycemia and surgical site infection. J Trauma Acute Care Surg (2014) 1.38
Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditions. Proc Natl Acad Sci U S A (2002) 1.30
Production of 2-methyl-1-butanol in engineered Escherichia coli. Appl Microbiol Biotechnol (2008) 1.29
A global regulatory role of gluconeogenic genes in Escherichia coli revealed by transcriptome network analysis. J Biol Chem (2005) 1.26
Inferring yeast cell cycle regulators and interactions using transcription factor activities. BMC Genomics (2005) 1.26
Synthetic non-oxidative glycolysis enables complete carbon conservation. Nature (2013) 1.24
Next generation biofuel engineering in prokaryotes. Curr Opin Chem Biol (2013) 1.23
Metabolic engineering of Clostridium cellulolyticum for production of isobutanol from cellulose. Appl Environ Microbiol (2011) 1.22
Design and characterization of synthetic fungal-bacterial consortia for direct production of isobutanol from cellulosic biomass. Proc Natl Acad Sci U S A (2013) 1.21
High-flux isobutanol production using engineered Escherichia coli: a bioreactor study with in situ product removal. Appl Microbiol Biotechnol (2011) 1.21
Transcriptome network component analysis with limited microarray data. Bioinformatics (2006) 1.21
Engineering of an Escherichia coli strain for the production of 3-methyl-1-butanol. Appl Environ Microbiol (2008) 1.20
Zebrafish larvae exhibit rheotaxis and can escape a continuous suction source using their lateral line. PLoS One (2012) 1.20
Contrast-enhanced whole-heart coronary MRA at 3.0T for the evaluation of cardiac venous anatomy. Int J Cardiovasc Imaging (2010) 1.17
Engineering metabolic systems for production of advanced fuels. J Ind Microbiol Biotechnol (2009) 1.17
Combined inactivation of the Clostridium cellulolyticum lactate and malate dehydrogenase genes substantially increases ethanol yield from cellulose and switchgrass fermentations. Biotechnol Biofuels (2012) 1.16
Differential association of hemoglobin with proinflammatory high density lipoproteins in atherogenic/hyperlipidemic mice. A novel biomarker of atherosclerosis. J Biol Chem (2007) 1.16
Thermosensitive injectable hyaluronic acid hydrogel for adipose tissue engineering. Biomaterials (2009) 1.15
Enantioselective synthesis of pure (R,R)-2,3-butanediol in Escherichia coli with stereospecific secondary alcohol dehydrogenases. Org Biomol Chem (2009) 1.14
Antibiotic resistance amongst healthcare-associated pathogens in China. Int J Antimicrob Agents (2012) 1.13
Vasodilator-stimulated phosphoprotein (VASP) phosphorylation provides a biomarker for the action of exisulind and related agents that activate protein kinase G. Mol Cancer Ther (2002) 1.12
Single-cell zeroth-order protein degradation enhances the robustness of synthetic oscillator. Mol Syst Biol (2007) 1.11
A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques. Clin Vaccine Immunol (2012) 1.10
Acetolactate synthase from Bacillus subtilis serves as a 2-ketoisovalerate decarboxylase for isobutanol biosynthesis in Escherichia coli. Appl Environ Microbiol (2009) 1.10
Improvement of isopropanol production by metabolically engineered Escherichia coli using gas stripping. J Biosci Bioeng (2010) 1.09
Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthrax. J Infect Dis (2011) 1.08
Using network component analysis to dissect regulatory networks mediated by transcription factors in yeast. PLoS Comput Biol (2009) 1.08
3-Methyl-1-butanol production in Escherichia coli: random mutagenesis and two-phase fermentation. Appl Microbiol Biotechnol (2010) 1.08
Microbial synthesis of n-butanol, isobutanol, and other higher alcohols from diverse resources. Bioresour Technol (2012) 1.08
Celecoxib-induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G. Mol Carcinog (2008) 1.08
Nitric oxide reaction with red blood cells and hemoglobin under heterogeneous conditions. Proc Natl Acad Sci U S A (2002) 1.06
VEGF receptor antagonism blocks arteriogenesis, but only partially inhibits angiogenesis, in skeletal muscle of exercise-trained rats. Am J Physiol Heart Circ Physiol (2004) 1.05
Maternal exposure to polycyclic aromatic hydrocarbons diminishes murine ovarian reserve via induction of Harakiri. J Clin Invest (2007) 1.05
Erythrocyte nitric oxide transport reduced by a submembrane cytoskeletal barrier. Biochim Biophys Acta (2005) 1.04
Heat shock response of Archaeoglobus fulgidus. J Bacteriol (2005) 1.03
Glycerol kinase deficiency alters expression of genes involved in lipid metabolism, carbohydrate metabolism, and insulin signaling. Eur J Hum Genet (2007) 1.03
Rainbow trout consume less oxygen in turbulence: the energetics of swimming behaviors at different speeds. J Exp Biol (2011) 1.03
A selection platform for carbon chain elongation using the CoA-dependent pathway to produce linear higher alcohols. Metab Eng (2012) 1.01
Targeted disruption of glycerol kinase gene in mice: expression analysis in liver shows alterations in network partners related to glycerol kinase activity. Hum Mol Genet (2005) 1.01
Specific cGMP binding by the cGMP binding domains of cGMP-binding cGMP specific phosphodiesterase. Cell Signal (2002) 1.00
Engineering synthetic recursive pathways to generate non-natural small molecules. Nat Chem Biol (2012) 1.00
Engineering a synthetic pathway in cyanobacteria for isopropanol production directly from carbon dioxide and light. Metab Eng (2013) 0.99
Tumor necrosis factor stimulates matrix metalloproteinase 9 secretion from cultured human chorionic trophoblast cells through TNF receptor 1 signaling to IKBKB-NFKB and MAPK1/3 pathway. Biol Reprod (2010) 0.99
Rhodopseudomonas palustris CGA009 has two functional ppsR genes, each of which encodes a repressor of photosynthesis gene expression. Biochemistry (2006) 0.98
Extending carbon chain length of 1-butanol pathway for 1-hexanol synthesis from glucose by engineered Escherichia coli. J Am Chem Soc (2011) 0.96
Energy biotechnology. Curr Opin Biotechnol (2012) 0.96
Analysis of nitric oxide consumption by erythrocytes in blood vessels using a distributed multicellular model. Ann Biomed Eng (2003) 0.95
Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency. Aging Cell (2011) 0.95
A synthetic recursive "+1" pathway for carbon chain elongation. ACS Chem Biol (2012) 0.95
A generalized framework for network component analysis. IEEE/ACM Trans Comput Biol Bioinform (2006) 0.94
Enhanced sensitivity and stability of room-temperature NH₃ sensors using core-shell CeO₂ nanoparticles@cross-linked PANI with p-n heterojunctions. ACS Appl Mater Interfaces (2014) 0.94
Evaluation of multiplex flow cytometric opsonophagocytic assays for determination of functional anticapsular antibodies to Streptococcus pneumoniae. Clin Vaccine Immunol (2006) 0.94
Identification of differentially expressed proteins in colorectal cancer by proteomics: down-regulation of secretagogin. Proteomics (2006) 0.94
Global metabolic effects of glycerol kinase overexpression in rat hepatoma cells. Mol Genet Metab (2007) 0.94
Comparison of cytotoxic and inflammatory responses of pristine and functionalized multi-walled carbon nanotubes in RAW 264.7 mouse macrophages. J Hazard Mater (2012) 0.93